Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients.

Anna GrendaEwelina IwanPaweł KrawczykMałgorzata FrąkIzabela ChmielewskaArkadiusz BombaAleksandra GizaAnna Rolska-KopińskaMichał SzczyrekRobert KieszkoTomasz KucharczykBożena JaroszDariusz WasylJanusz Milanowski

Published in: Cancers (2022)

class in gut microbiota could affect the effectiveness of immunotherapy, as well as the length of survival of NSCLC patients who received this method of treatment.

Keyphrases

small cell lung cancer
end stage renal disease
ejection fraction
randomized controlled trial
newly diagnosed
advanced non small cell lung cancer
systematic review
patient reported outcomes
combination therapy
free survival